Advancing Understanding of Allergic Disease
Join the International Journal of Allergy (IJA) for priority publication in allergic mechanisms, immunotherapy, environmental triggers, diagnostic advances, and clinical management of hypersensitivity disorders requiring rigorous scientific investigation and clinical validation. Our community connects allergists, immunologists, and researchers worldwide working to improve outcomes for the billions affected by allergic conditions through rigorous scientific investigation and evidence-based clinical practice development.
Immune Defense Research
From molecular mechanisms to clinical trials, IJA publishes research spanning the full spectrum of allergic disease science and therapeutic innovation for patients with hypersensitivity disorders requiring evidence-based care.
Excellence in Allergy Science Publishing
Expert Immunology Review
Review by allergists, clinical immunologists, and basic science researchers who understand IgE-mediated reactions, T-cell responses, and the complex mechanisms underlying hypersensitivity disorders and therapeutic interventions across the spectrum of allergic conditions from mild rhinoconjunctivitis to life-threatening anaphylaxis requiring expert clinical management.
Rapid 21-Day Decisions
Streamlined workflow delivers first decisions within 21 days, essential for time-sensitive research on emerging allergens, outbreak investigations, and novel therapeutic approaches requiring rapid dissemination to the clinical community for translation into improved patient care and outcomes across allergy practice settings.
Global Open Access
Published research reaches allergists, immunologists, and healthcare providers worldwide without subscription barriers, maximizing research impact and ensuring findings translate into improved patient care across healthcare settings globally, from academic medical centers to community allergy practices serving diverse patient populations.
Translational Focus
We prioritize research bridging basic immunology with clinical allergy practice, from laboratory discovery of allergic mechanisms to clinical validation of diagnostic tests and therapeutic interventions for improved patient outcomes and quality of life for those affected by allergic conditions.
Environmental Research
Climate change and environmental factors increasingly influence allergic disease patterns. IJA welcomes research on pollen trends, air quality impacts, and the environmental epidemiology of allergic conditions worldwide, from pollen patterns to indoor allergen exposures and occupational sensitization.
Network Access
Connect with allergy research centers, clinical immunology laboratories, and pharmaceutical partners for collaborative research opportunities advancing understanding and treatment of hypersensitivity disorders requiring rigorous scientific investigation and clinical validation.
Investment Options
All tiers include rigorous peer review, DOI assignment, and comprehensive indexing for maximum research visibility
- 1 Article APC Waiver
- Unlimited submissions
- Priority review handling
- Language editing services
- 2 Article APC Waivers
- Expedited review process
- Editorial board eligibility
- Membership certificate
- Coverage for 25 articles
- Centralized billing
- Multiple author support
- Dedicated account manager
Allergy and Immunology Focus Areas
Allergic Mechanisms
Understanding the immunological basis of allergic reactions remains fundamental to developing better treatments. IJA publishes research on IgE-mediated responses, mast cell biology, eosinophil function, and the complex cellular and molecular interactions underlying hypersensitivity that inform therapeutic development and clinical decision-making for allergic patients.
Immunotherapy Advances
Allergen immunotherapy offers disease-modifying potential for allergic conditions. IJA welcomes research on subcutaneous and sublingual immunotherapy, biologics targeting allergic pathways, and novel approaches to inducing tolerance in sensitized patients with food allergies, respiratory allergies, and venom hypersensitivity.
Diagnostic Innovation
Accurate diagnosis drives appropriate treatment. IJA publishes research on component-resolved diagnostics, basophil activation testing, molecular allergology, and improved approaches to identifying specific sensitization patterns that guide therapeutic decisions and personalized allergy treatment plans.
Editorial Opportunities
Join our editorial board to shape allergy research publishing. Handle manuscripts in your specialty from food allergy to respiratory hypersensitivity. Propose special issues on emerging topics including precision medicine approaches and novel immunomodulatory strategies and biologic therapies targeting specific allergic pathways.
Food Allergy Research
Food allergies affect millions globally with significant impact on quality of life and risk of severe reactions. IJA publishes research on peanut, tree nut, milk, egg, and other food allergies from mechanistic studies to clinical management guidelines and emerging oral immunotherapy protocols.
Respiratory Allergy
Allergic rhinitis, allergic asthma, and related conditions represent the most common allergic diseases. IJA welcomes research on aeroallergen sensitization, nasal and bronchial inflammation, and integrated treatment approaches for patients with respiratory allergic conditions affecting patient quality of life and productivity.
Drug Hypersensitivity
Adverse drug reactions pose significant clinical challenges. IJA publishes research on immediate and delayed hypersensitivity reactions, desensitization protocols, predictive testing, and optimal approaches to managing patients with drug allergy histories requiring careful evaluation and management in clinical settings.
Pediatric Allergy
Early life allergic sensitization sets trajectories for lifelong disease. IJA welcomes research on the allergic march, prevention strategies, pediatric-specific treatment considerations, and approaches to managing allergic diseases across the developmental spectrum from infancy through adolescence when allergic disease patterns are established.
IJA maintains strict editorial independence. All submissions undergo rigorous double-blind peer review regardless of membership tier. Our reviewers evaluate manuscripts for scientific rigor, clinical relevance, and potential to advance understanding and treatment of allergic diseases. This ensures the IJA seal represents excellence in allergy and immunology research worldwide, from pollen patterns to indoor allergen exposures and occupational sensitization.
Ready to Publish Your Allergy Research?
Submit for expert peer review and global Open Access. Contact [email protected] for membership inquiries. Whether studying allergic mechanisms, developing immunotherapies, or investigating environmental triggers, IJA provides expert reviewers and worldwide visibility.